MedPath
HSA Approval

NOVERON SOLUTION FOR INJECTION 10MG/ML

SIN17025P

NOVERON SOLUTION FOR INJECTION 10MG/ML

NOVERON SOLUTION FOR INJECTION 10MG/ML

June 12, 2024

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS

Medical Information

M03AC09

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

PT. Novell Pharmaceutical Laboratories

Active Ingredients

Rocuronium Bromide

10mg/ml

Rocuronium

Documents

Package Inserts

Noveron Solution for Injection PI.pdf

Approved: June 12, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NOVERON SOLUTION FOR INJECTION 10MG/ML - HSA Approval | MedPath